These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 8599194

  • 1. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.
    Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM.
    Virology; 1996 Mar 01; 217(1):11-22. PubMed ID: 8599194
    [Abstract] [Full Text] [Related]

  • 2. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G, Calmard L, Thouvenot D, Levrey H, Jagneaux V, Poitevin F, Malcus C, Accart N, Séné C, Layani MP, Aymard M, Bienvenu J, Courtney M, Döring G, Gilly B, Gilly R, Lamy D, Morel Y, Paulin C, Perraud F, Rodillon L, So S, Touraine F, Schatz C, Pavirani A.
    C R Seances Soc Biol Fil; 1996 Mar 01; 190(1):109-42. PubMed ID: 8881273
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Human adenovirus type 35: nucleotide sequence and vector development.
    Gao W, Robbins PD, Gambotto A.
    Gene Ther; 2003 Nov 01; 10(23):1941-9. PubMed ID: 14528318
    [Abstract] [Full Text] [Related]

  • 5. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H, Zhao T, Pastore L, Nageh M, Zheng W, Rao XM, Beaudet AL.
    Mol Ther; 2001 Apr 01; 3(4):613-22. PubMed ID: 11319924
    [Abstract] [Full Text] [Related]

  • 6. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
    Sargent KL, Ng P, Evelegh C, Graham FL, Parks RJ.
    Gene Ther; 2004 Mar 01; 11(6):504-11. PubMed ID: 14999222
    [Abstract] [Full Text] [Related]

  • 7. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
    Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA.
    Gene Ther; 2001 Jun 01; 8(11):846-54. PubMed ID: 11423932
    [Abstract] [Full Text] [Related]

  • 8. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
    Hodges BL, Serra D, Hu H, Begy CA, Chamberlain JS, Amalfitano A.
    J Gene Med; 2000 Jun 01; 2(4):250-9. PubMed ID: 10953916
    [Abstract] [Full Text] [Related]

  • 9. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
    Alemany R, Dai Y, Lou YC, Sethi E, Prokopenko E, Josephs SF, Zhang WW.
    J Virol Methods; 1997 Nov 01; 68(2):147-59. PubMed ID: 9389404
    [Abstract] [Full Text] [Related]

  • 10. In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.
    Bout A, Imler JL, Schultz H, Perricaudet M, Zurcher C, Herbrink P, Valerio D, Pavirani A.
    Gene Ther; 1994 Nov 01; 1(6):385-94. PubMed ID: 7584104
    [Abstract] [Full Text] [Related]

  • 11. Adenovirus-mediated generation of cAMP-stimulated Cl- transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method.
    Zabner J, Wadsworth SC, Smith AE, Welsh MJ.
    Gene Ther; 1996 May 01; 3(5):458-65. PubMed ID: 9156806
    [Abstract] [Full Text] [Related]

  • 12. ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo.
    Nicolis E, Tamanini A, Melotti P, Rolfini R, Berton G, Cassatella MA, Bout A, Pavirani A, Cabrini G.
    Gene Ther; 1998 Jan 01; 5(1):131-6. PubMed ID: 9536274
    [Abstract] [Full Text] [Related]

  • 13. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL, Bout A, Dreyer D, Dieterlé A, Schultz H, Valerio D, Mehtali M, Pavirani A.
    Hum Gene Ther; 1995 Jun 01; 6(6):711-21. PubMed ID: 7548271
    [Abstract] [Full Text] [Related]

  • 14. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
    Barjot C, Hartigan-O'Connor D, Salvatori G, Scott JM, Chamberlain JS.
    J Gene Med; 2002 Jun 01; 4(5):480-9. PubMed ID: 12221641
    [Abstract] [Full Text] [Related]

  • 15. Gene therapy for cystic fibrosis: current issues.
    Southern KW.
    Br J Hosp Med; 2002 Jun 01; 55(8):495-9. PubMed ID: 8732222
    [No Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC.
    Gene Ther; 1994 May 01; 1(3):192-200. PubMed ID: 7584081
    [Abstract] [Full Text] [Related]

  • 17. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.
    Wang Q, Jia XC, Finer MH.
    Gene Ther; 1995 Dec 01; 2(10):775-83. PubMed ID: 8750018
    [Abstract] [Full Text] [Related]

  • 18. Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein.
    Ban H, Inoue M, Griesenbach U, Munkonge F, Chan M, Iida A, Alton EW, Hasegawa M.
    Gene Ther; 2007 Dec 01; 14(24):1688-94. PubMed ID: 17898794
    [Abstract] [Full Text] [Related]

  • 19. [Prospects of gene therapy in mucoviscidosis using viral infection of the airway epithelium].
    Bayle JY, Boucher RC.
    Rev Mal Respir; 1994 Dec 01; 11(4):345-55. PubMed ID: 7526426
    [Abstract] [Full Text] [Related]

  • 20. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells.
    Fajac I, Allo JC, Souil E, Merten M, Pichon C, Figarella C, Monsigny M, Briand P, Midoux P.
    J Gene Med; 2000 Dec 01; 2(5):368-78. PubMed ID: 11045431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.